HealthcareServices

Customized Genetic Testing Global Forecast: Market to Scale Up to $29.5 Billion by 2030 at 15.8% CAGR

February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the customized genetic testing market from 2026–2035 with trusted insights from The Business Research Company

How much is the Customized Genetic Testing Market valued at in 2026, and what valuation is forecast for 2030?

The customized genetic testing market has witnessed rapid expansion in recent years. This market is set to grow from $14.13 billion in 2025 to $16.4 billion by 2026, with a compound annual growth rate (CAGR) of 16.0%. The historical growth of this market can be linked to increased understanding of hereditary diseases, a decrease in the cost of genetic sequencing, the broadening of clinical genetic counseling services, a rise in the adoption of predictive testing, and the expanding utilization of molecular diagnostics.

The customized genetic testing market size is expected to experience rapid growth in the upcoming years. It is projected to reach $29.5 billion by 2030, with a compound annual growth rate (CAGR) of 15.8%. The anticipated growth during this forecast period can be attributed to factors such as an increasing demand for personalized medicine, the rising integration of genomics in routine care, the expansion of preventive healthcare strategies, the growing adoption of precision oncology, and increasing investment in genomic data platforms. Major trends expected in this timeframe include the increasing adoption of personalized genetic panels, the growing use of NGS-based customized testing, the expansion of pharmacogenomic applications, a rising demand for targeted risk assessment, and enhanced integration of clinical decision support systems.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28187&type=smp

What Drivers Are Influencing The Growth Of The Customized Genetic Testing Market?

The increasing integration of personalized medicine is projected to accelerate the expansion of the customized genetic testing market moving forward. Personalized medicine signifies a healthcare strategy where medical treatments, preventative measures, and health-related decisions are tailored to each patient’s unique characteristics. This growing uptake of personalized medicine is attributed to advancements in genomics, proteomics, and biomarker discovery, which facilitate individualized treatments based on specific genetic profiles, thereby stimulating the demand for targeted therapies, enhanced diagnostics, and precise healthcare solutions. Customized genetic testing plays a vital role in this progression by offering detailed genetic insights that enable accurate disease risk assessments, focused therapeutic approaches, and proactive preventive care. For instance, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that in 2023, the United States Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients, compared to just 6 approvals in 2022. Thus, the escalating adoption of personalized medicine is propelling the growth of the customized genetic testing market.

How Is The Customized Genetic Testing Market Organized Into Various Segments?

The customized genetic testing market covered in this report is segmented –

1) By Test Type: Predictive Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing

2) By Sample Type: Saliva, Blood, Buccal Swab

3) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray Analysis, Single-Cell Sequencing

4) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Metabolic Disorders

5) By End-User: Predictive Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing

Subsegments:

1) By Predictive Testing: Cancer Susceptibility Testing, Neurodegenerative Disorder Testing, Cardiovascular Disease Risk Testing, Metabolic Disorder Risk Testing

2) By Carrier Testing: Cystic Fibrosis Carrier Testing, Sickle Cell Anemia Carrier Testing, Tay–Sachs Disease Carrier Testing, Thalassemia Carrier Testing

3) By Prenatal And Newborn Testing: Non-Invasive Prenatal Testing (NIPT), Newborn Screening Panels, Chorionic Villus Sampling (CVS), Amniocentesis-Based Genetic Testing

4) By Diagnostic Testing: Rare Disease Diagnosis, Oncology Genetic Testing, Neurological Disorder Diagnosis, Infectious Disease-Associated Genetic Testing

5) By Pharmacogenomic Testing: Drug Metabolism Testing, Oncology Pharmacogenomics, Cardiovascular Drug Response Testing, Psychiatric Drug Response Testing

How Are New Market Trends Shaping The Landscape Of The Customized Genetic Testing Market?

Major companies operating within the customized genetic testing market are increasingly prioritizing direct-to-consumer solutions, specifically at-home DNA testing combined with personalized health plans derived from individual genetic profiles. At-home DNA testing is a form of genetic assessment that individuals can conduct outside a clinical setting, typically by obtaining a kit online or from a pharmacy, collecting a saliva or cheek swab sample at home, and then mailing it to a laboratory for evaluation. For instance, in May 2025, Hydreight Technologies Inc., a digital health technology company based in Canada, introduced a personalized genetic testing and wellness offering on its VSDHOne Platform. This service provides patients with convenient access to at-home DNA testing kits and delivers customized health plans addressing nutrition, fitness, supplementation, and medication compatibility. Additionally, the platform ensures continuity of care through integrated telehealth services and in-person consultations delivered by licensed healthcare professionals.

Who Are The Primary Competitors In The Global Customized Genetic Testing Market?

Major companies operating in the customized genetic testing market are Guardant Health, Tempus, Invitae, 23andMe, Labcorp, Quest Diagnostics, Revvity Omics (PerkinElmer Genomics), Natera, Myriad Genetics, BGI Genomics, CENTOGENE, Veracyte, Fulgent Genetics, LetsGetChecked, Helix, MedGenome, Baylor Genetics, Prenetics, Eurofins (Clinical Genetics), Mapmygenome, Nebula Genomics

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/customized-genetic-testing-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Customized Genetic Testing Market?

North America was the largest region in the customized genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the customized genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Customized Genetic Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28187&type=smp

Browse Through More Reports Similar to the Global Customized Genetic Testing Market 2026, By The Business Research Company

Genetic Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Genetic Testing Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-services-global-market-report

Direct To Consumer Dtc Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/direct-to-consumer-dtc-genetic-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795